Janus Kinase Inhibitors (JAK inhibitors)

Janus Kinase Inhibitors (JAK inhibitors) are medications that target specific enzymes called Janus kinases, which play a key role in how the immune system responds and communicates. By blocking these enzymes, JAK inhibitors can reduce inflammation and immune activity, making them useful for treating autoimmune conditions like rheumatoid arthritis and certain other inflammatory diseases. They help control abnormal immune responses that cause tissue damage, providing relief for symptoms and helping prevent disease progression. These drugs are generally taken orally and are designed to offer targeted immune modulation with fewer side effects compared to broader immunosuppressants.